Lycopene for the prevention of prostate cancer (Q24235388)

https://api.crossref.org/works/10.1002%2F14651858.CD008007.PUB2

Tangerine tomatoes increase total and tetra-cis-lycopene isomer concentrations more than red tomatoes in healthy adult humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008007.PUB2

Mechanisms of disease: Prostate cancer--a model for cancer chemoprevention in clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008007.PUB2

Design of Physicians' Health Study II--a randomized trial of beta-carotene, vitamins E and C, and multivitamins, in prevention of cancer, cardiovascular disease, and eye disease, and review of results of completed trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008007.PUB2

Effects of beta-carotene supplementation on cancer incidence by baseline characteristics in the Physicians' Health Study (United States).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008007.PUB2

A randomized, controlled chemoprevention trial of selenium in familial prostate cancer: Rationale, recruitment, and design issues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008007.PUB2

Beta-carotene supplementation and cancer risk: a systematic review and metaanalysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008007.PUB2

A nutrient approach to prostate cancer prevention: The Selenium and Vitamin E Cancer Prevention Trial (SELECT)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008007.PUB2

Tomatoes, tomato products and lycopene in the prevention and treatment of prostate cancer: do we have the evidence from intervention studies?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008007.PUB2

Intake of selenium in the prevention of prostate cancer: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008007.PUB2

Prostate cancer: a serious disease suitable for prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008007.PUB2

A permutation test for a weighted Kaplan-Meier estimator with application to the nutritional prevention of cancer trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008007.PUB2

Vitamins E and C in the prevention of prostate and total cancer in men: the Physicians' Health Study II randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008007.PUB2

The Outcome of Selenium and Vitamin E Cancer Prevention Trial (SELECT) reveals the need for better understanding of selenium biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008007.PUB2

The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008007.PUB2

Efficacy of antioxidant vitamins and selenium supplement in prostate cancer prevention: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008007.PUB2

SELECT: the selenium and vitamin E cancer prevention trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008007.PUB2

Selenium and vitamin E cancer prevention trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008007.PUB2

Update on chemoprevention of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008007.PUB2

Vitamin E in the prevention of prostate cancer: where are we today?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008007.PUB2

Manganese superoxide dismutase polymorphism, prediagnostic antioxidant status, and risk of clinical significant prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008007.PUB2

A latent class mixed model for analysing biomarker trajectories with irregularly scheduled observations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008007.PUB2

Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008007.PUB2

Larry Clark's legacy: randomized controlled, selenium-based prostate cancer chemoprevention trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008007.PUB2

Antioxidant vitamin and mineral supplementation and prostate cancer prevention in the SU.VI.MAX trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008007.PUB2

The role of inflammation in the pathogenesis of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008007.PUB2

Dietary supplement use and prostate cancer risk in the Carotene and Retinol Efficacy Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008007.PUB2

Review of vitamin E and selenium in the prevention of prostate cancer: implications of the selenium and vitamin E chemoprevention trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008007.PUB2

Vitamin E and heart disease: basic science to clinical intervention trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008007.PUB2

Dietary intervention studies and cancer prevention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008007.PUB2

Tomato-based food products for prostate cancer prevention: what have we learned?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008007.PUB2

Prostate cancer prevention: what do we know now and when will we know more?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008007.PUB2

Lycopene and soy isoflavones in the treatment of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008007.PUB2

Diet and dietary supplement intervention trials for the prevention of prostate cancer recurrence: a review of the randomized controlled trial evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008007.PUB2

Incidence of cancer and mortality following alpha-tocopherol and beta-carotene supplementation: a postintervention follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008007.PUB2

Associations between alpha-tocopherol, beta-carotene, and retinol and prostate cancer survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008007.PUB2

Critical review of complementary therapies for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008007.PUB2

Manganese superoxide dismutase (MnSOD) polymorphism, alpha-tocopherol supplementation and prostate cancer risk in the alpha-tocopherol, beta-carotene cancer prevention study (Finland).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008007.PUB2

Associations between breast cancer risk and the catalase genotype, fruit and vegetable consumption, and supplement use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008007.PUB2

Mortality results from a randomized prostate-cancer screening trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008007.PUB2

A comparison of lycopene and orchidectomy vs orchidectomy alone in the management of advanced prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008007.PUB2

Tomatoes versus lycopene in oxidative stress and carcinogenesis: conclusions from clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008007.PUB2

Use of complementary and alternative medicine in men with family history of prostate cancer: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008007.PUB2

Total and specific complementary and alternative medicine use in a large cohort of men with prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008007.PUB2

Improved prediction of prostate cancer recurrence through systems pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008007.PUB2

Is there a benefit from lycopene supplementation in men with prostate cancer? A systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008007.PUB2

Effects of lycopene and tomato paste extracts on DNA and lipid oxidation in LNCaP human prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008007.PUB2

Screening for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008007.PUB2

Screening for prostate cancer: an updated Cochrane systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008007.PUB2

Dietary supplements commonly used for prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008007.PUB2

Types of alternative medicine used by patients with breast, colon, or prostate cancer: predictors, motives, and costs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008007.PUB2

Complementary and alternative medicine for advanced prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008007.PUB2

Plasma carotenoids and recurrence-free survival in women with a history of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008007.PUB2

Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: the Prostate Cancer Outcomes Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008007.PUB2

The use of complementary therapy by men with prostate cancer in the UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008007.PUB2

5-alpha-reductase inhibitors for prostate cancer prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008007.PUB2

Randomized, double-blind, placebo-controlled crossover study in men with prostate cancer and rising PSA: effectiveness of a dietary supplement

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008007.PUB2

Designing the Selenium and Vitamin E Cancer Prevention Trial (SELECT)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008007.PUB2

Relationship between serum prostate specific antigen and histological prostatitis in patients with benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008007.PUB2

7 January 2021

Beta-carotene supplementation for patients with low baseline levels and decreased risks of total and prostate carcinoma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008007.PUB2

7 January 2021

The selenium and vitamin E cancer prevention trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008007.PUB2

7 January 2021

Lycopene as a chemopreventive agent in the treatment of high-grade prostate intraepithelial neoplasia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008007.PUB2

7 January 2021

Prostate cancer epidemiology

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008007.PUB2

7 January 2021

Prevention of prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008007.PUB2

7 January 2021

Diet and prostate cancer risk in a cohort of smokers, with a specific focus on calcium and phosphorus (Finland)

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008007.PUB2

7 January 2021

Prostate cancer: neither vitamin E nor selenium prevents prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008007.PUB2

7 January 2021

A randomized trial of lycopene supplementation in Tobago men with high prostate cancer risk

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008007.PUB2

7 January 2021

Effects of alpha-tocopherol and beta-carotene supplements on cancer incidence in the Alpha-Tocopherol Beta-Carotene Cancer Prevention Study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008007.PUB2

7 January 2021

Dietary factors of one-carbon metabolism and prostate cancer risk

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008007.PUB2

7 January 2021

Lycopene inhibits the growth of human androgen-independent prostate cancer cells in vitro and in BALB/c nude mice.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008007.PUB2

7 January 2021

How do intermediate endpoint markers respond to lycopene in men with prostate cancer or benign prostate hyperplasia?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008007.PUB2

7 January 2021

Lycopene inhibits disease progression in patients with benign prostate hyperplasia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008007.PUB2

7 January 2021

Prostate Cancer and Supplementation With α-Tocopherol and β-Carotene: Incidence and Mortality in a Controlled Trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008007.PUB2

7 January 2021

Cigarettes: a smoking gun in cancer chemoprevention

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008007.PUB2

7 January 2021

Prospective evaluation of two recruitment strategies for a randomized controlled cancer prevention trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008007.PUB2

7 January 2021

Selenium, genetic variation, and prostate cancer risk: epidemiology reflects back on selenium and vitamin E cancer prevention trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008007.PUB2

7 January 2021

10.1002/14651858.CD008007.PUB2

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

22071840

1 reference

Consolidated OpenCitations Corpus – April 2017